Fluoxetine Discontinuation Tapering Strategy
Fluoxetine should be discontinued using dose reduction in stages over time, with the taper guided by the pharmacokinetic profile and treatment duration (Class recommended; level not specified in the cited guideline). [1]
Fluoxetine may be discontinued more easily than other antidepressants because of its prolonged duration of action. [1]
Stopping Process and Monitoring
Dose reduction to zero should be performed in a step-wise fashion, with prescribing at each step a proportion of the previous dose (example given: 50% of the previous dose). [1]
Smaller reductions (example given: 25%) should be used as the dose becomes lower. [1]
Withdrawal speed and overall duration should be led by and agreed with the person taking the medication, with assurance that withdrawal symptoms have resolved or are tolerable before further reductions. [1]
During tapering, monitoring should address both withdrawal symptoms and return of depressive symptoms. [1]
Withdrawal symptoms can begin within a few days of reducing or stopping antidepressants and usually resolve within 1–2 weeks, although symptoms can sometimes last longer, and severe symptoms are more likely with sudden cessation. [1]
Fluoxetine-Specific Taper Approach
When reducing fluoxetine, the half-life and long duration of action should be incorporated into the taper plan. [1]
For people taking 20 mg fluoxetine daily, alternate-day dosing can provide a suitable dose reduction strategy. [1]
For people taking higher doses (40–60 mg fluoxetine daily), a gradual withdrawal schedule should be used. [1]
After each dose-reduction step, 1–2 weeks should be allowed to evaluate the effects before considering further dose reductions. [1]
Initiation Thresholds for Slower Tapering
A slower taper and smaller decrements should be used when withdrawal symptoms occur with dose reduction. [1]
More severe withdrawal symptoms should prompt consideration of restarting the original antidepressant medication at the previous dose, followed by a slower re-attempt at dose reduction after symptoms have resolved. [1]
Expected Withdrawal Symptom Patterns
Abrupt discontinuation or missed doses can precipitate withdrawal symptoms, which can vary by individual and can include unsteadiness or dizziness, altered sensations, irritability or anxiety, low mood or tearfulness, panic attacks, confusion, restlessness or agitation, sleep problems, sweating, abdominal symptoms, palpitations, tiredness, headaches, and muscle or joint aches. [1]
Sudden stopping of fluoxetine can also produce withdrawal-like symptoms such as mood changes, irritability, agitation, dizziness, anxiety, sweating, confusion, headache, tiredness, and sleep difficulty. [2]
Medication Change Safety Considerations
A gradual reduction in dose rather than abrupt cessation is recommended whenever possible due to the medication’s long elimination half-lives and sustained decline in plasma concentrations at the end of therapy. [3]
If discontinuation is pursued, interactions and delayed clinical effects can occur because dose changes may not be fully reflected in plasma for several weeks. [3]
Situations Requiring Immediate Clinical Contact
If suicidal thoughts emerge during dose reduction or discontinuation, urgent clinical evaluation should be sought because withdrawal symptoms and relapse can both include very rarely suicidal thoughts. [1]
Duration of Taper
Withdrawal may take weeks or months to complete successfully. [1]